About Primo
Our Company
Facilities
Partnership Opportunities
Careers
Radioligand Theranostics
Pipeline
Products and Services
Radiopharmaceuticals
Isotopes
CRO and CDMO
Delivering
Precision Medicine
News
Press Releases
Events
Publications
繁體中文
About Primo
Our Company
Facilities
Partnership Opportunities
Careers
Radioligand Theranostics
Pipeline
Products and Services
Radiopharmaceuticals
Isotopes
CRO and CDMO
Delivering
Precision Medicine
News
Press Releases
Events
Publications
Contact Us
Contact Us
All
Press Releases
Events
Publications
Clinical efficacy of radium-223 in simulating real-world clinical practice: a meta-analysis
2026-04-08
Publications
Radium-223’s Impact on Skeletal Events in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
2025-11-13
Publications
Cost-Utility Analysis of 18F-FDG Imaging: A Network Meta-Analysis of Diagnostic Modalities
2025-11-13
Publications
Radiopharmaceuticals: New Drug Development Process and the Importance of Preclinical Research
2025-11-01
Publications
Procedures for GMP-Compliant Production of [¹⁷⁷Lu]Lu-PSMA-I&T, Quality Control, and Evaluation of Stability Over Five Days
2025-11-01
Publications
First Automated Radiosynthesis of [161Tb]Tb-PSMA-I&T in Taiwan Using the iPHASE MultiSyn Synthesizer
2025-11-01
Publications
An updated radiosynthesis of [18F]PSMA-1007 by a Neptis RS synthesizer with fully EP compliant quality control test at the medical center in Northern Taiwan.
2024-11-02
Publications
Clinical Impact of Radium-223 on Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
2024-11-02
Publications
The radiosynthesis of [18F]fluoroacetate by a Tracerlab MX synthesizer in Shin-Kong Memorial Hospital.
2024-11-02
Publications
Does 18F-PSMA-1007 PET/CT Effectively Detect Among Patients with Suspected Prostate Cancer-Case Report
2024-08-16
Publications
The evaluation in the efficacy of Radium-223 for overall survival among patients with mCRPC: A meta-analysis
2024-08-16
Publications
Application of Radelumin(PSMA-1007) combined with MRS(Magnetic resonance spectroscopy) in assessment of benign and malignant prostate cancer.
2024-08-16
Publications
Posts pagination
1
2